Specialty Pharmacy

Men diagnosed with cancer under age 25 far less likely to have children and more likely to take infertility drugs.

Charlie Sheen's announcement that he is HIV-positive may lead to a new era of HIV preventative efforts.

Several chemotherapy agents have been investigated for neoadjuvant use in HER2-positive breast cancer.

Less than half of adolescents and young adults who survive Hodgkin lymphoma receive recommended services within the first year after treatment.

Sites and apps such as Grindr, Manhunt, Scruff, Adam4Adam, and Craigslist may be linked with higher STD incidences.

Zepatier is approved for the treatment of patients with chronic hepatitis C virus genotypes 1 and 4.

Mergers and acquisitions among pharmacy benefit managers may help limit medication cost hikes.

Researchers created a model framework to compare costs of 7 common regimens to treat relapsed and/or refractory multiple myeloma.

Viekirax and Exviera combination showed promising results in the treatment of patients with chronic HCV genotype 1b with compensated cirrhosis.

Combination of sialidase and cucurbitacin I shows substantial antitumor activity in sarcoma therapy.

Drugs like Viagra could improve insulin sensitivity and secretion without diminishing fibrinolytic function.

Toll-like receptor 4 behave differently on psoriasis skin compared with uninvolved skin.

Top stories of the week on The American Journal of Pharmacy Benefits.

The combined impact of anti-cancer treatments and exercise holds promise for shrinking tumors.

Recent advances and updates in oncology and cancer drug development.

Prior studies have found that Rac1 is a molecule that maintains chronic neuropathic pain resulting from injury to the nervous system.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

High doses of biotin show promise in progressive multiple sclerosis.

Everolimus (Afinitor) treats progressive, non-functional neuroendocrine tumors of gastrointestinal or lung origin.

Gazyva plus bendamustine provides a new option to significantly reduce the risk of death.

The management of individual chemotherapy regimens by pharmacists improves safety by reducing medication errors.

FDA approval for Gazyva gives new option to patients with follicular lymphoma who did not respond to a regimen containing rituximab (Rituxan).

Researchers compare side effects for top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Researchers compare top selling hep C medications Zepatier, Sovaldi, Harvoni, and Viekira Pak.

Cytokine IL-36 found to drive some inflammatory processes while helping to resolve the inflammation in IBD patients.

Researchers evaluate impact of medical cannabis on conditions such as rheumatoid arthritis, fibromyalgia and osteoarthritis.

Top stories of the week on Specialty Pharmacy Times.

Personal concerns about HIV status jeopardizing existing relationships could affect patient adherence behaviors.